The present study confirmed the findings that an increase in TNF‐α, IL‐1β and IL‐6 levels, and a reduction of IL‐10 concentration in brain tissues with CIS administration compared to the control group was associated with the triggering of the inflammatory cascade. The gene discussed is IL1B; the disease is in situ carcinoma.